3D Medicines Inc. (1244.HK)

HKD 3.34

(-1.47%)

Operating Expenses Summary of 3D Medicines Inc.

  • 3D Medicines Inc.'s latest annual operating expenses in 2023 was 585.85 Million CNY , up 18.98% from previous year.
  • 3D Medicines Inc.'s latest quarterly operating expenses in 2024 Q2 was 121.82 Million CNY , down 0.0% from previous quarter.
  • 3D Medicines Inc. reported a annual operating expenses of 846.54 Million CNY in annual operating expenses 2022, up 51.42% from previous year.
  • 3D Medicines Inc. reported a annual operating expenses of 559.06 Million CNY in annual operating expenses 2021, up 83.95% from previous year.
  • 3D Medicines Inc. reported a quarterly operating expenses of 121.82 Million CNY for 2024 Q2, down 0.0% from previous quarter.
  • 3D Medicines Inc. reported a quarterly operating expenses of 242.59 Million CNY for 2023 Q2, down 0.0% from previous quarter.

Annual Operating Expenses Chart of 3D Medicines Inc. (2023 - 2020)

Historical Annual Operating Expenses of 3D Medicines Inc. (2023 - 2020)

Year Operating Expenses Operating Expenses Growth
2023 585.85 Million CNY 18.98%
2022 846.54 Million CNY 51.42%
2021 559.06 Million CNY 83.95%
2020 303.92 Million CNY 0.0%

Peer Operating Expenses Comparison of 3D Medicines Inc.

Name Operating Expenses Operating Expenses Difference
Uni-Bio Science Group Limited 325.05 Million HKD -80.236%
CK Life Sciences Int'l., (Holdings) Inc. 739.25 Million HKD 20.75%